Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin

LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-s

100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamabFull data

100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamab Full data

NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately

Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.

U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.6

U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.6

ADC Therapeutics stock plunges 53% after-hours as investors focus on safety concerns in a phase III

ADC Therapeutics shares slumped nearly 53% in premarket trading on Thursday after a late-stage study

Shares of PVH fell 21.42% in pre-market trading even after strong Q1. Gainers include CXApp, TaoWeav

ADC Therapeutics SA (ADCT) Discusses Phase III LOTIS-5 Trial Results and Next Steps in DLBCL Transcr

Company to host conference call today at 4:30 p.m. EDT LAUSANNE, Switzerland, June 3, 2026 /PRNewswi

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers f

ADC Therapeutics SA remains a Strong Buy, driven by pivotal ZYNLONTA combination trials targeting 2n

ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call Transcript

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.21 per share versus the Zacks Consen

LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7

Here is how ADC Therapeutics SA (ADCT) and Bioventus (BVS) have performed compared to their sector s

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

  On Monday, 79 companies reached new 52-week lows.

  On Tuesday, 838 companies hit new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.